Exact matches only
Search in title
Search in content
Search in posts
Search in pages
portfolio
Filter by Categories
ADAM
Architecture
Big Data
Bio-IT World
Bioinformatics
Blog
Cases
cBioPortal
Consultancy
CTMM TraIT
Data Curation
Data Management
FAIR
Galaxy
Harry van Haaften
IMI EMIF
IMI ETRIKS
IMI Translocation
Irina Pulyakhina
Janneke Schoots
Jarno van Erp
Jojanneke Blaak
Joris Borgdorff
Kees van Bochove
Maxim Monait
Natalia Boukharov
OMOP and OHDSI
Open source
Peter Kok
Pieter Lukasse
Piotr Zakrzewski
RADAR CNS
Rianne Jansen
Riza Nugraha
Services
Seth Snel
Sjoerd van Hagen
Software Development
Software Engineering
Software licenses
Software licenses
Solutions
Spark
Team
Topics
Translational Research
tranSMART
TranSMART 2.0
Uncategorized
Ward Weistra
Wibo Pipping

Bernd van der Veen

Software Engineer

@TheHyveNL

Harvard Business School (HBS) announced on the 20th of May 2016, that Dana-Farber’s MatchMiner has been named the winner of the Precision Trials Challenge.

A joint developmental effort between Dana-Farber’s KSG group, located in Boston, headed by Ethan Cerami PhD, and The Hyve, also located in Boston, has resulted in the inception of MatchMiner, an open computational platform for matching patient-specific genomic profiles to precision cancer medicine clinical trials.

The MatchMiner platform aims to accelerate enrollment in precision medicine clinical trials and maximize clinical trial options for all patients. It is currently being developed in two distinct stages at Dana-Farber, after which point the entire platform will be made fully open source, and available to other institutions. The first stage of the platform is focused on “trial-centric” matching, enabling clinical trial investigators to create individualized genomic filters, and use these filters to forecast clinical trial enrollment, retrospectively identify new patients for clinical trials, and receive alerts of newly sequenced patients matching specific genomic criteria. The second stage of the platform is focused on “patient-centric” matching, enabling any clinician to view matching clinical trials for their specific patient, based on genomic eligibility and real-time clinical trial enrollment slot availability. Stage 1 is now live at Dana-Farber and is currently being used by multiple clinical trial teams.

MatchMiner will receive the $50,000 first prize and an opportunity to share their winning idea at the annual Personalized Medicine Conference (PMC) at Harvard Medical School, where the ideation challenge was first announced last year. Two runners-up were awarded $25,000 each for their innovative ideas.

The Hyve has facilitated the development of the user interface whereas the group of Ethan Cerami PhD was responsible for the development of the core backend, the API and the curating of the data consumed by the MatchMiner platform.

dana farber logo the hyve

Leave a Reply

Your email address will not be published. Required fields are marked *

Bernd van der Veen

Software Engineer

@TheHyveNL